SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1676But MOGN's market cap is about 1.5 billion right now. I don't know thattuck-5/12/2006
1675Wockhardt mulls buying US-based MGI Pharma: Sources Sources have told CNBC-TV18Icebrg-5/12/2006
1674Should have taken some people by surprise. The PDUFA-date was May 15th. ErikIcebrg-5/3/2006
1673U.S. FDA Approves Dacogen(TM) (Decitabine) for Injection Wednesday May 3, 7:00 asim1-5/3/2006
1672>>MGI Loses Less Than Expected By Althea Chang TheStreet.com Staff Reportuck-4/20/2006
1671MGI Pharma Sees Sales Miss By TSC Staff 4/13/2006 8:08 AM EDT MGI PharmDoc Bones-4/13/2006
1670While generic Zofran is a threat to Aloxi, the spray form being developed by Hantuck-4/3/2006
1669Gliadel® Wafer Improves Survival in Aggressive Gliomas According to a presIcebrg-3/31/2006
1668Aside from the Aquavan news, I'd say the bigger driver if the recent share ptuck-3/22/2006
1667MGI PHARMA Announces Initiation of Aquavan(R) Injection Pivotal Program Monday Msim1-3/20/2006
1666Longer Treatment With Dacogen (decitabine) Advised for Pre-Leukemia By Judith Icebrg-3/14/2006
1665MGI Pharma "neutral," target price reduced Friday, March 10, 2006 2:5Icebrg-3/11/2006
1664Gliadel(R) Wafer Demonstrates Long-Term Survival Benefit for Patients with High-Icebrg-3/8/2006
1663>>i read some report somewhere that generic zofran wont have as much impactuck-2/9/2006
1662i value this company by its price to sales ratio and growth rate...still seems csammaster-2/8/2006
1661MOGN misses, as expenses related to Guilford munch were higher than expected. &#tuck-2/8/2006
1660kk i get it now :) this is just a new formulation of kytril... and its doing a ssammaster-1/29/2006
1659<i>fight aloxi patent</i> Nope - this is a quite different drug (KyBiomaven-1/29/2006
1658<i>"A sponsor of a 505(b)(2) application for a change to a listed drusammaster-1/27/2006
1657I don't know. This was just something that popped up on one of my news scansIcebrg-1/27/2006
1656noninferiority study or superiority study?sammaster-1/26/2006
1655A.P. Pharma Announces Submission of APF530 Pivotal Trial Protocol for FDA ReviewIcebrg-1/26/2006
1654Board of Directors Compensation Schedule. On January 17, 2006, the Board of DirIcebrg-1/24/2006
1653aloxi sales to outpatient oncology offices and hospital based "outpatient&qsammaster-1/12/2006
1652"Anyone else got a take or strategy here?" FWIW, my strategy is selliRocky9-1/11/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News